author-photo

Wenyu Shi

University of Texas MD Anderson Cancer Center

4

Papers

16

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK+ T-cell lymphoma

2019 Journal of Hematology & Oncology
Show All
- Source
- Cite
- Save
Citations (7)
TrkA is a binding partner of NPM‐ALK that promotes the survival of ALK+ T‐cell lymphoma

2017 Molecular Oncology
Show All
- Source
- Cite
- Save
Citations (5)
Targeting Notch1 and proteasome as an effective strategy to suppress T-cell lymphoproliferative neoplasms

2015 Oncotarget
Show All
- Source
- Cite
- Save
Citations (4)
Trka, a Novel Binding Partner of NPM-ALK Oncogenic Tyrosine Kinase, Facilitates the Survival of T-Cell Anaplastic Large-Cell Lymphoma

2014 Blood
Show All
- Source
- Cite
- Save
Citations (0)